1. Live market news
  2. Stocks
  3. GMAB

Genmab AS

GMABStockUSA

36.81USD−0.56 (−1.50%)Delayed · 13 Oct, 14:31 UTC
About

Genmab AS

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab (Suzhou) Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

Key figures

Previous close
37.37
Open
37.23
Day range
36.81 – 37.23
52-week range
—
Volume
888K

In detailthe same figures as in Oyticker Charts

Performance

1D−1.5%

Ranges & volume

Day36.81 – 37.23
52 weeks—
Open
37.23
Prev. close
37.37
Volume 888Kavg —

Risk · 1 year

Not enough historyRisk needs at least a month of daily sessions.

Seasonality

Not enough historySeasonality needs several months of data.
SEC filings

What GMAB filed

All its filings

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.